It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Ribosome biogenesis is a multi-step process, in which a network of trans-acting factors ensures the coordinated assembly of pre-ribosomal particles in order to generate functional ribosomes. Ribosome biogenesis is tightly coordinated with cell proliferation and its perturbation activates a p53-dependent cell-cycle checkpoint. How p53-independent signalling networks connect impaired ribosome biogenesis to the cell-cycle machinery has remained largely enigmatic. We demonstrate that inactivation of the nucleolar SUMO isopeptidases SENP3 and SENP5 disturbs distinct steps of 40S and 60S ribosomal subunit assembly pathways, thereby triggering the canonical p53-dependent impaired ribosome biogenesis checkpoint. However, inactivation of SENP3 or SENP5 also induces a p53-independent checkpoint that converges on the specific downregulation of the key cell-cycle regulator CDK6. We further reveal that impaired ribosome biogenesis generally triggers the downregulation of CDK6, independent of the cellular p53 status. Altogether, these data define the role of SUMO signalling in ribosome biogenesis and unveil a p53-independent checkpoint of impaired ribosome biogenesis.
Ribosome biogenesis is tightly coordinated with cell-cycle progression. By characterizing the SUMO isopeptidases SENP3/SENP5, Doenig et al. identify a long-sought p53-independent impaired ribosome checkpoint that converges on downregulation of CDK6.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details








1 Goethe University Frankfurt, Medical Faculty, Institute of Biochemistry II, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721)
2 University Medical Centre Göttingen, Department of Molecular Biology, Göttingen, Germany (GRID:grid.411984.1) (ISNI:0000 0001 0482 5331)
3 Goethe University Frankfurt, Medical Faculty, Institute of Biochemistry II, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721); PharmBioTec gGmbH, Schiffweiler, Germany (GRID:grid.7839.5)
4 Goethe University Frankfurt, Medical Faculty, Institute of Biochemistry II, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721); Sanofi AG, Frankfurt, Germany (GRID:grid.420214.1)
5 Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Berlin, Germany (GRID:grid.6363.0) (ISNI:0000 0001 2218 4662); German Cancer Consortium (DKTK), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); Max Delbrück Center, Berlin, Germany (GRID:grid.419491.0) (ISNI:0000 0001 1014 0849)
6 Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Berlin, Germany (GRID:grid.6363.0) (ISNI:0000 0001 2218 4662); German Cancer Consortium (DKTK), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); Max Delbrück Center, Berlin, Germany (GRID:grid.419491.0) (ISNI:0000 0001 1014 0849); University Medical Center Göttingen, Department of General, Visceral and Pediatric Surgery, Göttingen, Germany (GRID:grid.411984.1) (ISNI:0000 0001 0482 5331)
7 Goethe University Frankfurt, Medical Faculty, Institute of Biochemistry II, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721); German Cancer Consortium (DKTK), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584)